<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753983</url>
  </required_header>
  <id_info>
    <org_study_id>20-006464</org_study_id>
    <nct_id>NCT04753983</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy</brief_title>
  <official_title>fMRI of Active DBS Stimulation in Epilepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to use functional imaging to study the mechanisms of the&#xD;
      anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Researchers are testing how changing the settings on deep brain stimulation device (DBS) can&#xD;
      help reduce the number and severity of seizures. Functional imaging will be used to study the&#xD;
      mechanisms of ANT DBS to optimize the device settings to improve the degree of seizure&#xD;
      reduction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">April 1, 2023</start_date>
  <completion_date type="Anticipated">May 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Document brain activation networks with ANT stimulation</measure>
    <time_frame>Results would be available immediately following processing of the imaging data after each scan</time_frame>
    <description>Use resting state fMRI to map brain network activation with high and low frequency of ANT stimulation.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Refractory Epilepsy</condition>
  <arm_group>
    <arm_group_label>Anterior Nucleus of the Thalamus (ANT) Deep Brain Stimulation (DBS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects that have undergone DBS placement for treatment of refractory epilepsy will undergo a fMRI scan. During the fMRI, the subject will undergo alternating short periods of their DBS in the &quot;on&quot; and &quot;off&quot; state with high- and low frequency settings to measure the brain activation changes induced by the DBS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Functional magnetic resonance imaging (fMRI)</intervention_name>
    <description>Diagnostic imaging measuring the metabolic changes that occur within the brain used for measuring and mapping brain activity</description>
    <arm_group_label>Anterior Nucleus of the Thalamus (ANT) Deep Brain Stimulation (DBS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Patients who have previously undergone anterior thalamic nucleus deep brain stimulation&#xD;
        (DBS) for refractory epilepsy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Contraindication to MRI; prior brain resective surgery or large area of brain tissue loss&#xD;
        (e.g., large area infarction).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven A Messina, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 9, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>August 9, 2021</last_update_submitted>
  <last_update_submitted_qc>August 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Steven A. Messina</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Deep Brain Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

